Sleep Medicine Reviews
Volume 7, Issue 5 , Pages 441-444 , October 2003

Integrating psychosocial and biomedical CPAP adherence models. A commentary on: “Improving CPAP use by patients with the sleep apnea/hypopnea syndrome (SAHS)” (HM Engleman & MR Wild)

  • Barry Krakow

      Affiliations

    • Sleep & Human Health Institute, Albuquerque, NM USA
    • University of New Mexico Health Sciences Center, Albuquerque, NM USA
    • Department of Psychiatry, University of New Mexico School of Medicine, USA
    • Department of Emergency Medicine, University of New Mexico School of Medicine, USA
    • Maimonides Sleep Arts & Sciences, Ltd. Albuquerque, NM USA
    • ,
  • Dominic Melendrez

      Affiliations

    • Sleep & Human Health Institute, Albuquerque, NM USA
    • Maimonides Sleep Arts & Sciences, Ltd. Albuquerque, NM USA
    • ,
  • Patricia Haynes

      Affiliations

    • San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California, USA

References 

  1. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev. 2003;7:81–99
  2. Krakow B, Melendrez D, Ferreira E, Clark J, Warner TD, Sisley B, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest. 2001;120:1923–1929
  3. Krakow B, Melendrez D, Warner TD, Dorin R, Harper R, Hollifield M. To breathe, perchance to sleep: sleep-disordered breathing and chronic insomnia among trauma survivors. Sleep Breath. 2002;6:189–202
  4. Guilleminault C, Palombini L, Poyares D, Chowdhuri S. Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res. 2002;53:611–615
  5. Guilleminault C, Palombini L, Poyares D, Chowdhuri S. Chronic insomnia, postmenopausal women and sleep disordered breathing: part 2. Comparison of nondrug treatment trials in normal breathing and UARS postmenopausal women complaining of chronic insomnia. J Psychosom Res. 2002;53:617–623
  6. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res. 2002;11:1–16
  7. Ball EM, Banks MB. Determinants of compliance with nasal continuous positive airway pressure treatment applied in a community setting. Sleep Med. 2001;2:195–205
  8. Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment?. Respir Med. 2000;94:145–149
  9. Perlis, MLLichstein, KL, Treating Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine, John Wiley & Sons, Inc.
  10. Ruhle KH, Fahrner A, Randerath W. [Evaluating oronasal flow with temperature (thermistor) and obstructive pressure (prongs)]. Pneumologie. 2001;55:4–6
  11. Guilleminault C, Stoohs R, Kim YD, Chervin R, Black J, Clerk A. Upper airway sleep-disordered breathing in women. Ann Intern Med. 1995;122:493–501
  12. Norman RG, Ahmed MM, Walsleben JA, Rapoport DM. Detection of respiratory events during NPSG: nasal cannula/pressure sensor versus thermistor. Sleep. 1997;20:1175–1184
  13. Melendrez D, Krakow BJ, Hall M. A new airflow sensor for the detection of flow limitation in sleep-disordered breathing. Sleep. 2002;25:A222
  14. Sleep. 1999;22:667–689

PII: S1087-0792(02)90288-1

doi: 10.1053/smrv.2002.0288

Sleep Medicine Reviews
Volume 7, Issue 5 , Pages 441-444 , October 2003

Article Tools